Research & Development.
Translational research on peptide therapeutics, regenerative formulations, and precision medicine protocols, grounded in real-world clinical outcomes.
The QOL Project™
Where Science, Education, and Therapeutics Converge
QOL Project™ is the research and development engine behind a new model of precision medicine and regenerative aesthetics. Every formulation, every training protocol, and every clinical innovation that reaches a patient, a physician, or a partner originates here.
Founded by Dr. Christie Prendergast, DO FACS and her pHD team, QOL Project™ transforms over a decade of frontline clinical data and proprietary compounds into scalable science, structured education, and next-generation therapeutics.
QOL Project™ is the research and development engine behind a new model of precision medicine and regenerative aesthetics. Every formulation, every training protocol, and every clinical innovation that reaches a patient, a physician, or a partner originates here.
Founded by Dr. Christie Prendergast, DO FACS and her pHD team, QOL Project™ transforms over a decade of frontline clinical data and proprietary compounds into scalable science, structured education, and next-generation therapeutics.
Three pillars, one mission
Education.
QOL Institute™ certifies physicians in peptide therapy, precision medicine, and regenerative aesthetics, setting a new standard for clinical training.
Therapeutics.
Proprietary formulations and protocols, developed and protected under QOL Project™.
Built for what's next
QOL Project™ is redefining how compounds get validated against human biology, replacing guesswork with organoid modeling, AI-driven analysis, and personalized biomarkers. This is the next generation of precision medicine and regenerative aesthetics, built on evidence rather than assumption.
Discover how to partner with QOL Project™. See Contact.